S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
"Prepare for Five Years of Famine" (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
"Prepare for Five Years of Famine" (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
"Prepare for Five Years of Famine" (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
"Prepare for Five Years of Famine" (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
LON:HVO

hVIVO - HVO Share Forecast, Price & News

GBX 14.95
-0.45 (-2.92%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
14.60
15.50
50-Day Range
10
21.50
52-Week Range
9.20
23.40
Volume
1.78 million shs
Average Volume
2.68 million shs
Market Capitalization
£100.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HVO stock logo

About hVIVO (LON:HVO) Stock

hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services.

hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.

Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Stock News Headlines

hVIVO plc (HVO.L)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
3 no-brainer UK shares to buy in February
We Might See A Profit From hVIVO plc (LON:HVO) Soon
Hvivo Plc Share Price (HVO.GB.PL)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
1 penny stock I’m buying right now!
Is hVIVO plc (LON:HVO) Potentially Undervalued?
1 penny stock under 13p I’d snap up right now
Open Orphan Share Chat
Hvivo Plc Share Chat
Hvivo Share News (HVO)
HVIVO PLC
Can hVIVO (LON:HVO) Afford To Invest In Growth?
Successful RSV Challenge Study in Older Adults
Hvivo Share Chat (HVO)
RSV Challenge Model Delivers Positive Results
See More Headlines
Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Company Calendar

Last Earnings
4/19/2018
Today
3/25/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£-1,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£34.71 million
Cash Flow
GBX 3.03 per share
Book Value
GBX 3 per share

Miscellaneous

Free Float
N/A
Market Cap
£100.32 million
Optionable
Not Optionable
Beta
1.13

Key Executives

  • Dr. Yamin Mohammed Khan Ph.D. (Age 54)
    CEO & Director
  • Mr. Stephen Pinkerton
    CFO & Exec. Director
  • Mr. Andrew Catchpole
    Chief Scientific Officer
  • Dr. Maurice N. Treacy Ph.D.
    Chief Commercial Officer
  • Ms. Teja Marathe-Sarvadikar
    Head of QA













HVO Stock - Frequently Asked Questions

How have HVO shares performed in 2023?

hVIVO's stock was trading at GBX 10 at the beginning of the year. Since then, HVO stock has increased by 49.5% and is now trading at GBX 14.95.
View the best growth stocks for 2023 here
.

How were hVIVO's earnings last quarter?

hVIVO plc (LON:HVO) issued its earnings results on Thursday, April, 19th. The company reported ($16.50) earnings per share for the quarter, missing analysts' consensus estimates of ($10.90) by $5.60. hVIVO had a negative net margin of 3.07% and a negative trailing twelve-month return on equity of 5.00%.

What other stocks do shareholders of hVIVO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY).

What is hVIVO's stock symbol?

hVIVO trades on the London Stock Exchange (LON) under the ticker symbol "HVO."

How do I buy shares of hVIVO?

Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is hVIVO's stock price today?

One share of HVO stock can currently be purchased for approximately GBX 14.95.

How much money does hVIVO make?

hVIVO (LON:HVO) has a market capitalization of £100.32 million and generates £34.71 million in revenue each year.

How can I contact hVIVO?

hVIVO's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The official website for the company is hvivo.com. The company can be reached via phone at +44-20-77561300.

This page (LON:HVO) was last updated on 3/25/2023 by MarketBeat.com Staff